Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001851416-26-000026
Filing Date
2026-08-11
Accepted
2026-08-11 13:28:21
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 7671
  Complete submission text file 0001851416-26-000026.txt   9629
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Subject) CIK: 0001716166 (see all company filings)

EIN.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92230 | Film No.: 261262202
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 303 E WACKER DRIVE SUITE 1040 CHICAGO IL 60601
Business Address 303 E WACKER DRIVE SUITE 1040 CHICAGO IL 60601 312-297-7000
Streeterville Capital LLC (Filed by) CIK: 0001851416 (see all company filings)

EIN.: 852954598 | State of Incorp.: UT | Fiscal Year End: 1231
Type: SCHEDULE 13G